Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay

Aβ(42) is one of the most extensively studied blood and Cerebrospinal fluid (CSF) biomarkers for the diagnosis of symptomatic and prodromal Alzheimer’s disease (AD). Because of the heterogeneity and transient nature of Aβ(42) oligomers (Aβ(42)Os), the development of technologies for dynamically dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liding, Du, Xuewei, Su, Ying, Niu, Shiqi, Li, Yanqing, Liang, Xiaohan, Luo, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597216/
https://www.ncbi.nlm.nih.gov/pubmed/34789291
http://dx.doi.org/10.1186/s12951-021-01111-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597216/
https://www.ncbi.nlm.nih.gov/pubmed/34789291
http://dx.doi.org/10.1186/s12951-021-01111-z

Ejemplares similares